What's new

Orphan designation: Zanidatamab Treatment of biliary tract cancer, 19/07/2021 Positive

Orphan designation: Zanidatamab Treatment of biliary tract cancer, 19/07/2021 Positive

Apr 25, 2025 - 15:03
 0
Orphan designation: Zanidatamab Treatment of biliary tract cancer, 19/07/2021 Positive
Orphan designation: Zanidatamab Treatment of biliary tract cancer, 19/07/2021 Positive
Read More

Tags:

Previous Article

Orphan designation: octreotide hydrochloride Treatment of acromegaly, 12/06/200...

Next Article

Orphan designation: (S)-2-amino-6-(2-hydroxypropanoyl)-7,8-dihydropteridin-4(3H)...

Related Posts

Summary of opinion: Amvuttra, 25/04/2025 Positive

Summary of opinion: Amvuttra, 25/04/2025 Positive

Apr 25, 2025  0

Orphan designation: (S)-2-amino-6-(2-hydroxypropanoyl)-7,8-dihydropteridin-4(3H)-one Treatment of hyperphenylalaninemia, 20/05/2021 Positive

Orphan designation: (S)-2-amino-6-(2-hydroxypropanoyl)-...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Nilotinib Accord, nilotinib, Date of authorisation: 22/08/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 23, 2025  0